Aprotinin administration in the pericardial cavity does not prevent platelet activation.

Maquelin, K N

Aprotinin administration in the pericardial cavity does not prevent platelet activation. [electronic resource] - The Journal of thoracic and cardiovascular surgery Sep 2000 - 552-7 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0022-5223

10.1067/mtc.2000.108530 doi


Aged
Aprotinin--administration & dosage
Cardiopulmonary Bypass
Double-Blind Method
Female
Flow Cytometry
Hemostatics--administration & dosage
Humans
Male
Middle Aged
Pericardium
Platelet Activation--drug effects
Platelet Glycoprotein GPIb-IX Complex--analysis